Video Experimental Relacionado
Updated: Jul 6, 2026
07:41
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Los retinoides son selectivos para las vías de respuesta del receptor retinoide X
J M Lehmann1, L Jong, A Fanjul
1Cancer Center, La Jolla Cancer Research Foundation, La Jolla, CA 92037.
Science (New York, N.Y.)
|December 18, 1992
Resumen
Los nuevos retinoides activan selectivamente los homodímeros de los receptores de retinoides X (RXR), independientemente de los receptores de ácido retinoico (RAR). Esto permite la activación independiente de distintas vías de señalización de retinoides.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Endocrinología Endocrinología.
- Farmacología Farmacología.
Sus antecedentes:
- Los retinoides son agentes terapéuticos cruciales con diversas actividades biológicas.
- La señalización de los retinoides está mediada principalmente por los receptores de ácido retinoico (RAR) y los receptores de retinoides X (RXR).
- Los RAR suelen funcionar como heterodímeros con los RXR para la unión al ADN y la regulación transcripcional.
Objetivo del estudio:
- Desarrollar nuevos retinoides capaces de dirigirse selectivamente a complejos específicos de receptores de retinoides.
- Investigar el potencial para la activación independiente de los homodímeros RXR frente a los heterodímeros RAR-RXR.
- Explorar nuevas estrategias terapéuticas mediante la disección de las vías de señalización de los retinoides.
Principales métodos:
- Síntesis y caracterización de una nueva serie de retinoides.
- Ensayos in vitro para evaluar la activación de los homodímeros RXR y los heterodímeros RAR-RXR.
- Análisis de las interacciones receptor-ligando y los efectos de señalización aguas abajo.
Principales resultados:
- Se identificó una nueva serie de retinoides que activa selectivamente los homodímeros RXR.
- Estos retinoides no demostraron ninguna activación significativa de los heterodímeros RAR-RXR.
- Se logró una modulación independiente de la actividad del homodímero RXR sin afectar la función del heterodímero RAR-RXR.
Conclusiones:
- Los hallazgos demuestran la viabilidad de la activación independiente de distintas vías de señalización de retinoides.
- Esta activación selectiva ofrece un nuevo enfoque para afinar las terapias basadas en retinoides.
- Dirigirse específicamente a los homodímeros RXR abre caminos para nuevas intervenciones terapéuticas con efectos fuera de objetivo reducidos.
Más Videos Relacionados
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Videos de Conceptos Relacionados
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:25Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
01:28Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...